We are live on ! Find out more
TCOV

Trust Company of Vermont Portfolio holdings

AUM $2.68B
This Fund
S&P 500
This Quarter Est. Return
+4.05%
1 Year Est. Return
–
3 Year Est. Return
–
5 Year Est. Return
–
10 Year Est. Return
–
AUM
$1.2B
AUM Growth
+$42.5M
Cap. Flow
+$2.61M
Cap. Flow %
0.22%
Top 10 Hldgs %
19.99%
Holding
1,087
New
93
Increased
215
Reduced
205
Closed
49

Top Buys

Rank Stock Value
1
CVS icon
CVS Health
CVS
+$1.6M
2
BND icon
Vanguard Total Bond Market
BND
+$1.2M
3
MSM icon
MSC Industrial Direct
MSM
+$832K
4
AMAT icon
Applied Materials
AMAT
+$793K
5
JPM icon
JPMorgan Chase
JPM
+$775K

Top Sells

Rank Stock Value
1
NVS icon
Novartis
NVS
+$1.18M
2
DD icon
DuPont de Nemours
DD
+$810K
3
FDX icon
FedEx
FDX
+$681K
4
XOM icon
ExxonMobil
XOM
+$545K
5
WFC icon
Wells Fargo
WFC
+$517K

Sector Composition

Rank Sector Weight
1 Technology 13.39%
2 Financials 13.27%
3 Healthcare 13.2%
4 Industrials 11.18%
5 Consumer Staples 9.25%
Name Market Value Portfolio Weight Shares or Principal Change
in Stake 		Capital Flow
FWRD icon
976
Forward Air
FWRD
$658M
– –
-38
Closed -$2K
HMC icon
977
Honda
HMC
$40.6B
– –
-270
Closed -$7K
HMY icon
978
Harmony Gold Mining
HMY
$12.4B
$0 ﹤0.01%
100
– –
IRWD icon
979
Ironwood Pharmaceuticals
IRWD
$714M
– –
-81
Closed -$1K
KBE icon
980
State Street SPDR S&P Bank ETF
KBE
$1.74B
– –
-150
Closed -$6K
LEG icon
981
Leggett & Platt
LEG
$1.29B
– –
-47
Closed -$2K
LIT icon
982
Global X Lithium & Battery Tech ETF
LIT
$1.61B
– –
-1,140
Closed -$32K
M icon
983
Macy's
M
$6.26B
– –
-117
Closed -$3K
MFM
984
Aberdeen Municipal Income Fund
MFM
$223M
– –
-2,500
Closed -$17K
MGA icon
985
Magna International
MGA
$18.6B
– –
-283
Closed -$14K
NKTR icon
986
Nektar Therapeutics
NKTR
$2.57B
– –
-1
Closed -$1K
NZF icon
987
Nuveen Municipal Credit Income Fund
NZF
$2.42B
– –
-961
Closed -$14K
OC icon
988
Owens Corning
OC
$12.3B
– –
-800
Closed -$38K
PZG icon
989
Paramount Gold Nevada
PZG
$130M
$0 ﹤0.01%
+250
New +$199
RITM icon
990
Rithm Capital
RITM
$5.71B
– –
-1,600
Closed -$27K
RTH icon
991
VanEck Retail ETF
RTH
$260M
– –
-43
Closed -$5K
SNAP icon
992
Snap
SNAP
$8.79B
$0 ﹤0.01%
20
– –
TEVA icon
993
Teva Pharmaceuticals
TEVA
$42.8B
$0 ﹤0.01%
49
– –
VGK icon
994
Vanguard FTSE Europe ETF
VGK
$31B
$0 ﹤0.01%
+9
New +$490
W icon
995
Wayfair
W
$14.1B
– –
-6
Closed -$1K
WBD icon
996
Warner Bros
WBD
$69.3B
– –
-56
Closed -$2K
WBS icon
997
Webster Financial
WBS
$12.8B
– –
-42
Closed -$2K
WDC icon
998
Western Digital
WDC
$157B
– –
-33
Closed -$1K
Z icon
999
Zillow
Z
$7.48B
– –
-26
Closed -$1K
BIG
1000
DELISTED
Big Lots, Inc.
BIG
$0 ﹤0.01%
10
– –
37 38 39
40
41

Similar funds

MMEA
Main Management ETF Advisors San Francisco, California $2.68B AUM 24.27% 1-Year Est. Return
VA
VR Adviser New York $2.68B AUM 422.73% 1-Year Est. Return
TCAM
Turtle Creek Asset Management Toronto, Ontario, Canada $2.67B AUM 0.64% 1-Year Est. Return
SFI
Susquehanna Fundamental Investments Bala Cynwyd, Pennsylvania $2.67B AUM 21.74% 1-Year Est. Return
LP
Longaeva Partners Chicago, Illinois $2.7B AUM 37.16% 1-Year Est. Return
HCM
Hollencrest Capital Management Newport Beach, California $2.7B AUM 23.62% 1-Year Est. Return
SCM
Shaolin Capital Management Miami, Florida $2.71B AUM 64.57% 1-Year Est. Return
PCIG
Partners Capital Investment Group Boston, Massachusetts $2.65B AUM 16.42% 1-Year Est. Return

Trust Company of Vermont's Q2 2019 Portfolio in Review

As of Q2 2019, Trust Company of Vermont held 1,087 positions worth $1.2B, up 3.7% from $1.16B the previous quarter. Its ten largest holdings account for 20% of the portfolio.

Trust Company of Vermont's Q2 2019 filing shows 93 new, 215 increased, 205 reduced and 49 closed positions. Its largest new stake was Dow Inc: 12,586 shares worth $620K. The largest sale was Novartis, an estimated $1.18M.

By sector, the portfolio is most concentrated in Technology at 13% of assets, up from 13% a quarter earlier, followed by Financials and Healthcare.

  • Trust Company of Vermont's largest Q2 2019 buy was Dow Inc: 12,586 shares worth $620K.
  • Trust Company of Vermont added most to CVS Health in Q2 2019, an estimated $1.6M increase.
  • Trust Company of Vermont's biggest Q2 2019 reduction was Novartis, cutting an estimated $1.18M.
  • Trust Company of Vermont fully exited Bemis in Q2 2019, selling an estimated $353K.
  • Trust Company of Vermont's ten largest holdings make up 20% of its $1.2B portfolio in Q2 2019.
  • Trust Company of Vermont opened 93 new positions and closed 49 in Q2 2019.
  • Trust Company of Vermont's portfolio value rose 3.7% quarter-over-quarter to $1.2B.

Based on Trust Company of Vermont's 13F filing for Q2 2019, filed 26 Jul 2019.